Preferred Pharmaceuticals, Inc. is recalling approximately 575 packs of Ondansetron ODT (ondansetron orally disintegrating tablets), 4mg, which were manufactured by Glenmark Pharmaceuticals. The recall was initiated after reports that the foil blister packs are not fully sealed, which can cause the tablets to fall out of their individual slots. This packaging defect was identified by the manufacturer, Glenmark, and affects tablets repackaged by Preferred Pharmaceuticals with specific lot numbers J1325J and I1725P.
The defective seal on the blister packs can compromise the integrity of the medication and lead to tablets falling out, which may result in patients missing doses or taking contaminated medication.
You have 2 options:
Manufactured by Glenmark Pharmaceuticals Limited and repackaged by Preferred Pharmaceuticals.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.